| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Section on Colorectal Cancer |
Tucker Gosnell Gastrointestinal Cancer Center, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA
Key Words. Nonsurgical • Radiofrequency ablation • Chemoembolization • Radiation
Correspondence: David P. Ryan, M.D., Medical Director, Tucker Gosnell Gastrointestinal Cancer Center, Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA. Telephone: 617-726-8515; Fax: 617-643-1894; e-mail: dpryan{at}partners.org
It is time to challenge the current orthodoxy that frowns upon surgical and nonsurgical methods of tumor reduction for patients with metastatic colon cancer. Although the studies conducted with radiofrequency ablation, chemoembolization, and radiation therapy in patients with metastatic colon cancer have tended to be small and may have been subject to selection bias, they have produced survival data that require careful consideration. At the very least, it is clear that loco regional approaches to debulking tumors are feasible and that their combination with systemic chemotherapy should be investigated.
This article has been cited by other articles:
![]() |
P. G. Johnston The Colorectal Cancer Coalition: Reflections on the Future Oncologist, October 1, 2006; 11(9): 970 - 972. [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |